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S U M M A R Y
Objectives: The objective of this study was to describe the sociodemographic and clinical characteristics
of patients dually infected with HIV and tuberculosis (TB) in Guyana.
Methods: The data for this study were obtained as part of a related project conducted to determine the
prevalence of diabetes mellitus among TB patients in Guyana. From April to June 2006, a convenience
sample of 100 patients was selected from those attending three TB clinics in Guyana and a structured
questionnaire was used to collect relevant sociodemographic and risk factor data. The sociodemographic
and clinical data of HIV-negative and HIV-positive patients with pulmonary TB were compared. Logistic
regression was conducted to determine independent relationships between sociodemographic and
clinical features.
Results: One hundred TB patients were considered for enrolment in the study, but since the HIV status
was known for only 77 persons, these were included in the analysis. Thirty-one of the 77 (40.3%) were
HIV-positive. Seventy-two of the 77 (93.5%) patients had pulmonary TB, 28 of whom were HIV-positive;
the other ﬁve had extrapulmonary TB, three of whom were dually infected. Several social factors and
clinical manifestations including incarceration at the time of TB diagnosis (p = 0.01), cigarette smoking
(p = 0.05), homelessness (p = 0.07), chest pain (p = 0.001), hemoptysis (p = 0.02), cough (p = 0.08), and
being acid-fast bacillus (AFB) sputum smear-positive (p = 0.06) were associated with HIV-negative
pulmonary TB. In the logistic regression model, HIV-negative TB patients demonstrated higher
frequencies of complaints of chest pain (odds ratio (OR) 34.48, 95% conﬁdence interval (CI) 4.35–250)
and were more likely to be AFB sputum smear-positive (OR 11.97, 95% CI 1.91–74.76) than HIV-positive
TB patients.
Conclusions: Guyana is faced with a particularly high burden of HIV infection among TB patients. Given
the impact of HIV on the clinical presentation of TB, physicians managing HIV patients should
demonstrate a high level of suspicion for TB among these patients. Incarceration is a strong correlate of
TB, overall.
 2012 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.
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Tuberculosis (TB) and HIV are intersecting epidemics in many
countries around the world. In 2004, an estimated 13% of newly
diagnosed cases of TB worldwide were co-infected with HIV, with
co-infection rates exceeding 30% in high prevalence countries.1–4
In the Americas, the Pan American Health Organization has
estimated that the prevalence of HIV among TB patients varies
from 0.7% to as high as 46%, with an average of 6%.5 In countries* Corresponding author. Tel.: +1 613 737 8899x74748; fax: +1 613 737 8324.
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http://dx.doi.org/10.1016/j.ijid.2012.05.1026such as Guyana, Trinidad and Tobago, and the Bahamas, HIV
prevalence in TB patients is more than 30%.5,6
Guyana is in the throes of a generalized HIV/AIDS epidemic with
an estimated adult seroprevalence of 2.5% and with approximately
4700–23 000 persons living with HIV/AIDS.7 HIV emerged in
Guyana in the late 1980s, with the ﬁrst AIDS case diagnosed in
1987. Concurrent with the emergence of HIV, Guyana saw the
resurgence of TB after many years of successful control during the
1970s and early 1980s. At the end of 2005, the annual TB incidence
was reported at 149/100 000 population and the prevalence at
194/100 000 population, which are among the highest in the
Americas.8 The re-emergence of TB in Guyana has closely followed
the emergence of HIV and AIDS. Poverty and the economic crisis of
the 1970s and 1980s are also factors that have contributed to theses. Published by Elsevier Ltd. All rights reserved.
Table 1
Sociodemographic characteristics of HIV-negative and HIV-positive patients with
pulmonary TB (N = 72)
Characteristic HIV-negative
TB patients
(n = 44)
HIV-positive
TB patients
(n = 28)
Sex
Male 61.4% 42.9%
Age group, years
0–14 4.5% 3.7%
15–24 15.9% 10.7%
25–34 25.0% 32.1%
35–44 29.6% 32.1%
>44 25.0% 21.4%
Ethnicity
African 38.6% 75.0%
Indian 45.5% 10.7%
Amerindian 9.1% 0%
Mixed 6.8% 14.3%
Employment
Unemployed 47.7% 57.1%
Employed 45.5% 35.7%
Other 6.8% 7.1%
TB, tuberculosis.
Table 2
Risk factors for HIV-negative and HIV-positive patients with pulmonary TB (N = 72)
HIV-negative
TB patients
(n = 44)
HIV-positive
TB patients
(n = 28)
p-Value
Exposure to infectious TB 72.7% 57.1% 0.21
Alcohol abuse 50.0% 39.3% 0.47
Cigarette smoking 45.5% 21.4% 0.05
Crack cocaine or marijuana use 31.8% 14.3% 0.16
Imprisonment 34.1% 7.1% 0.01
Homelessness 25.0% 7.1% 0.07
Steroid use 9.1% 14.3% 0.70
TB, tuberculosis.
Table 3
Clinical signs and symptoms in HIV-negative and HIV-positive patients with
pulmonary TB (N = 72)
HIV-negative
TB patients
(n = 44)
HIV-positive
TB patients
(n = 28)
p-Value
Weight loss 88.6% 75.0% 0.19
Cough 86.4% 67.9% 0.08
Night sweats 77.3% 64.3% 0.29
Chest pain 75.0% 35.7% 0.001
Fever 70.5% 57.1% 0.31
Hemoptysis 45.5% 17.9% 0.02
AFB sputum smear-positive 52.3% 28.6% 0.06
TB, tuberculosis; AFB, acid-fast bacillus.
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emergence of TB in many developing countries.1,2,9–11
The extent to which HIV affects the clinical presentation of TB is
a function of the degree of immunodeﬁciency produced by HIV. At
higher CD4 counts, HIV-infected patients will present with typical
reactivation pulmonary disease.12–14 With more pronounced
immunological deﬁciency, extrapulmonary TB is common, with
manifestations typical of the affected site.12–14 Pulmonary TB at
lower CD4 counts presents as primary TB, often with lower lobe
disease and involvement of mediastinal lymph nodes.13,15 Sputum
acid-fast bacillus (AFB) smears and cultures are often negative in
HIV patients, making the diagnosis of TB more difﬁcult.13,14
The objective of this study was to describe the sociodemo-
graphic and clinical characteristics of Guyanese patients dually
infected with HIV and TB.
2. Methods
The data for this study were obtained as part of another study
conducted to determine the prevalence of diabetes mellitus among
TB patients in Guyana. From April to June 2006, a convenience
sample of 100 consenting patients was selected from those
attending three large TB clinics in Guyana and a structured
questionnaire was used to collect relevant sociodemographic, risk
factor, and clinical data. TB patients were diagnosed by AFB
sputum smear microscopy, clinically, or radiologically and were
currently on treatment for TB.
The sociodemographic data and clinical features of pulmonary
TB in HIV-negative and HIV-positive patients were compared using
the Chi-square test, Fisher’s exact test, and the Student’s t-test.
Finally variables that were signiﬁcant at the univariate level were
entered into a logistic regression model to determine independent
associations of sociodemographic characteristics and clinical
manifestations of HIV-positive patients with pulmonary TB.
3. Results
One hundred TB patients presenting at three main TB clinics in
Guyana were included in this study. The majority of these patients
were from the TB clinic located in Georgetown, the capital city of
Guyana. Based on patient interviews and chart reviews, the HIV
status of only 77 patients could be determined, as there was no
record of an HIV test being offered or done for 23 patients. Of the 77
TB patients whose HIV status was known, 31 (40.3%) were HIV-
positive. Seventy-two of these 77 patients (93.5%) had pulmonary
TB and 28 (38.9%) of them were HIV-positive. The other ﬁve
patients had extrapulmonary TB, three of whom were dually
infected with HIV and TB.
The gender and age group distributions of HIV-positive and
HIV-negative patients with pulmonary TB were similar (Table 1).
Patients of Afro-Guyanese ethnicity were more likely to be HIV-
positive than other ethnicities (p = 0.002). Unemployment was
high in both groups (47.7% in HIV-negative and 57.1% in HIV-
positive patients). Several factors including incarceration at the
time of TB diagnosis (p = 0.01) and cigarette smoking (p = 0.05)
were associated with HIV-negative pulmonary TB patients (Table
2). Substance abuse (crack cocaine or marijuana) and homeless-
ness demonstrated marginal relationships with HIV-negative
pulmonary TB.
We examined the relationship of HIV and the clinical
presentation of pulmonary TB (Table 3). The overall trend was
that HIV-negative patients had more obvious clinical manifesta-
tions of pulmonary TB than co-morbid patients. However
statistical signiﬁcance was only achieved for chest pain
(p = 0.001), hemoptysis (p = 0.02), and cough (p = 0.08). HIV-negative pulmonary TB patients were also more likely to be AFB
sputum smear-positive than co-morbid cases (p = 0.06).
Finally, variables that were signiﬁcant (ethnicity, incarceration
at the time of TB diagnosis, cigarette smoking, crack cocaine or
marijuana use, chest pain, and hemoptysis) and marginally
signiﬁcant (homelessness, cough, and AFB sputum smear positivi-
ty) were entered into a logistic regression model. After adjusting
for these variables, Afro-Guyanese pulmonary TB patients were
much more likely to be HIV-infected than pulmonary TB patients of
other ethnicities (adjusted odds ratio (OR) 24.25, 95% conﬁdence
interval (CI) 3.36–175.25). Likewise HIV-negative pulmonary TB
patients were more likely have chest pain (OR 34.48, 95% CI 4.35–
250) and be AFB sputum smear-positive (OR 11.97, 95% CI 1.91–
74.76) than HIV-positive pulmonary TB patients.
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In this study of 77 TB patients attending three chest clinics in
Guyana, 40.3% were infected with HIV. In a previous report on
Guyanese TB patients, 35% were HIV-infected.6 While the TB–HIV
co-infection rate in this study is comparable to the co-morbidity
rates in other heavily affected countries in Africa, it is much higher
than the rates in many countries of the Americas.5,16 Therefore, HIV
infection should be an important consideration in TB patients in
Guyana. In this regard, the fact that the HIV status of 23% of the 100
patients initially considered for this study was unknown is a clear
indication that more emphasis has to be placed on ensuring that all
TB patients are screened for HIV. The rate of HIV screening of
patients in TB programs continues to be less than optimal, even in
developed countries like Canada.17 The policy of Guyana’s national
TB program is to offer HIV testing to all TB patients, but only those
who consent to this are tested. The high co-infection rate reported
here implies that a more aggressive HIV screening policy needs to
be implemented, including opt-out HIV testing. Controlling the
dual epidemics requires stronger linkages between TB and HIV
programs.9,18–21
Afro-Guyanese ethnicity was the only independent demo-
graphic factor associated with HIV infection in this study. This may
be the result of the large proportion of Afro-Guyanese patients
recruited into the study who were residents of HIV high-
prevalence communities in Georgetown and Linden. Social and
behavioral factors such as homelessness, cigarette smoking, and
recent imprisonment were found to be associated with HIV-
negative pulmonary TB. These factors are common risk factors for
TB;22 however the relative weight of risk factors and their own
associations might confound the adjusted analyses.
This study conﬁrms previous reports of a high frequency of AFB
sputum smear-negative pulmonary TB among HIV-positive
patients.12,23,24 The common occurrence of non-cavitary pulmo-
nary lesions in co-morbid patients is one of the determinants of
this phenomenon.15 Of concern is the overall high incidence of
sputum smear-negative TB in HIV-positive patients in Guyana
(71.4%). This likely indicates that a large proportion of Guyanese TB
patients are diagnosed using chest radiographs. In the hands of
inexperienced TB physicians this may result in an over-diagnosis of
pulmonary TB.
This study did not clearly demonstrate an impact of HIV on the
clinical presentation of pulmonary TB. Chest pain and hemoptysis
were directly linked to HIV-negative pulmonary TB. Many of the
symptoms (e.g., fever, weight loss, cough, etc.) associated with TB
are common in AIDS patients. Therefore, the absence of clear
clinical distinctions between HIV-negative and HIV-positive TB
patients is not unexpected. The diagnosis of pulmonary TB in HIV
patients requires heightened clinical awareness and must be an
important differential diagnosis in HIV patients with respiratory
conditions in Guyana.
Guyana is faced with a particularly high burden of HIV infection
among TB patients, and incarceration is a major risk factor.
Physicians managing HIV patients need a high level of suspicion for
TB among these patients. Likewise, TB physicians must ensure that
screening for HIV becomes a necessary requirement in the
evaluation of TB patients.
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